Contact: Paul Burghardt, a partner with CURES' Exposure Signatures Facility Core

The complex interactions of toxicants and other stressors have become an important consideration in our studies. CURES' research capacity for radio-immuno assays, plate-conjugated, enzyme-linked immunosorbent assays (ELISA), and a bead-based ELISA platform from Perkin Elmer called AlphaLISA has been expanded. AlphaLISA provides sensitivity that is less than radio-immuno assays but greater than ELISA. Analytes will be added to the set of validated assays as CURES investigators identify key mediators of stress or potential exposure signatures among the signaling molecules.

Services Provided:

• Radio-immuno assays
• Plate conjugated
• ELISA
• AlphaLISA

Return to the Resource List